Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management

Biologics targeting Th1/Th17 cytokines have revolutionised psoriasis treatment. In addition to treatment effectiveness, it is important to define and understand the long-term risks of biologic therapy in order to guide therapy selection and minimise these risks for patients where possible. This revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Janabi, A, Yiu, Z Z N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747772/
https://www.ncbi.nlm.nih.gov/pubmed/35024352
http://dx.doi.org/10.2147/PTT.S328575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747772/
https://www.ncbi.nlm.nih.gov/pubmed/35024352
http://dx.doi.org/10.2147/PTT.S328575

Ejemplares similares